What criteria did the FDA use to approve daridorexant for insomnia, and how does its dual orexin receptor antagonism mechanism differ from older non-benzodiazepine Z-drugs like zolpidem?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What criteria did the FDA use to approve daridorexant for insomnia, and how does its dual orexin receptor antagonism mechanism differ from older non-benzodiazepine Z-drugs like zolpidem?
1 real search · 1 real-search pass
FDA daridorexant approval criteria insomnia trials sleep onset maintenance daytime functioning zolpidem mechanism orexin receptor antagonist prescribing informationGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 1 queries…
Searches and sources
ChatGPT1 real searches · gpt-6
FDA daridorexant approval criteria insomnia trials sleep onset maintenance daytime functioning zolpidem mechanism orexin receptor antagonist prescribing information Google ↗
- Drug Trials Snapshots: QUVIVIQ · fda.gov
- These highlights do not include all the information needed to use QUVIVIQ safely and effectively. See full prescribing information for QUVIVIQ. QUVIVIQ (daridorexant) tablets, for oral use, CIV Initial U.S. Approval: 2022 · dailymed-us-east-1.awsprod.nlm.nih.gov
- Review · accessdata.fda.gov
- These highlights do not include all the information needed to use QUVIVIQ safely and effectively. See full prescribing information for QUVIVIQ. QUVIVIQ (daridorexant) tablets, for oral use, CIV Initial U.S. Approval: 2022 · dailymed.nlm.nih.gov
Queries
1 queries · click a column to sort